Guideline-Based Critical Care Pathway Improves Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome

[1]  Sidney C. Smith,et al.  2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. , 2019, Circulation. Cardiovascular quality and outcomes.

[2]  F. Zhang,et al.  Perspective of delay in door-to-balloon time among Asian population , 2018, Journal of geriatric cardiology : JGC.

[3]  C. Lau,et al.  Prognostic implications of early monomorphic and non-monomorphic tachyarrhythmias in patients discharged with acute coronary syndrome. , 2018, Heart rhythm.

[4]  Marco Valgimigli,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[5]  K. Fox,et al.  Treatment Patterns, Statin Intolerance, and Subsequent Cardiovascular Events Among Japanese Patients With High Cardiovascular Risk Initiating Statin Therapy. , 2017, Circulation journal : official journal of the Japanese Circulation Society.

[6]  Deepak L. Bhatt,et al.  2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. , 2017, Journal of the American College of Cardiology.

[7]  Deepak L. Bhatt,et al.  2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. , 2017, Circulation. Cardiovascular quality and outcomes.

[8]  M. Banach,et al.  Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction. , 2017, Journal of the American College of Cardiology.

[9]  U. Laufs,et al.  Pleiotropic Effects of Statins on the Cardiovascular System , 2017, Circulation research.

[10]  I. Komuro,et al.  The Current Status of Cardiovascular Medicine in Japan　- Analysis of a Large Number of Health Records From a Nationwide Claim-Based Database, JROAD-DPC. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[11]  Ching-Lan Cheng,et al.  Statin Adherence After Ischemic Stroke or Transient Ischemic Attack Is Associated With Clinical Outcome. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[12]  Maciej Banach,et al.  Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies , 2015, BMC Medicine.

[13]  Y. Lam,et al.  A single centre retrospective cohort study to evaluate the association between implementation of an acute myocardial infarction clinical pathway and clinical outcomes. , 2015, International journal of cardiology.

[14]  A. Jaffe,et al.  2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[15]  A. Jaffe,et al.  A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2015 .

[16]  Biykem Bozkurt,et al.  2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[17]  Haibo Zhang,et al.  Reperfusion times of ST-Segment elevation myocardial infarction in hospitals , 2014, Pakistan journal of medical sciences.

[18]  V. Fuster,et al.  Global Perspective on Acute Coronary Syndrome: A Burden on the Young and Poor , 2014, Circulation research.

[19]  V. Fuster,et al.  Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction). , 2014, Journal of the American College of Cardiology.

[20]  Xiang Ma,et al.  An analysis of the door-to-balloon time in STEMI patients in an underdeveloped area of China: a single-centre analysis , 2013, Emergency Medicine Journal.

[21]  Yaman Walid Kassab,et al.  Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice. , 2013, Journal of evaluation in clinical practice.

[22]  Jane A. Linderbaum,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[23]  Mark A Hlatky,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.

[24]  D. Atar,et al.  ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[25]  M. Mifune,et al.  The usefulness of the revised classification for chronic kidney disease by the KDIGO for determining the frequency of diabetic micro- and macroangiopathies in Japanese patients with type 2 diabetes mellitus. , 2012, Journal of diabetes and its complications.

[26]  K. Marzo,et al.  Beta Blocker Use After Acute Myocardial Infarction in the Patient with Normal Systolic Function: When is it “Ok” to Discontinue? , 2012, Current cardiology reviews.

[27]  Laura Mauri,et al.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Circulation.

[28]  Jeffrey L. Anderson,et al.  2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Circulation.

[29]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[30]  Mark D. Huffman,et al.  Presentation, management, and outcomes of 25 748 acute coronary syndrome admissions in Kerala, India: results from the Kerala ACS Registry. , 2013, European heart journal.

[31]  Access Investigators.  Management of acute coronary syndromes in developing countries: acute coronary events-a multinational survey of current management strategies. , 2011, American heart journal.

[32]  Thomas D. Scott,et al.  Predictors of reperfusion delay in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention from the HORIZONS-AMI trial. , 2010, The American journal of cardiology.

[33]  M. Jeong,et al.  Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value. , 2010, American heart journal.

[34]  Lingzhi Kong,et al.  Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. , 2009, American heart journal.

[35]  N. Vermeer,et al.  Utilization of evidence‐based therapy for the secondary prevention of acute coronary syndromes in Australian practice , 2008, Journal of clinical pharmacy and therapeutics.

[36]  Helen Y. Lee,et al.  Use of Secondary Prevention Drug Therapy in Patients With Acute Coronary Syndrome After Hospital Discharge , 2008, Journal of managed care pharmacy : JMCP.

[37]  F. Resnic,et al.  An analysis of door‐to‐balloon time in a single center to determine causes of delay and possibilities for improvement , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[38]  A. Yan,et al.  Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. , 2007, American heart journal.

[39]  J. Alpert,et al.  The universal definition of myocardial infarction: a consensus document , 2007, Heart.

[40]  R. Califf,et al.  The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes. , 2006, American heart journal.

[41]  Harlan M Krumholz,et al.  ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-El , 2006, Journal of the American College of Cardiology.

[42]  Robert Parrish,et al.  Guideline-based standardized care is associated with substantially lower mortality in medicare patients with acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) Projects in Michigan. , 2005, Journal of the American College of Cardiology.

[43]  K. Eagle,et al.  Medication performance measures and mortality following acute coronary syndromes. , 2005, The American journal of medicine.

[44]  A. Wolff,et al.  Using checklists and reminders in clinical pathways to improve hospital inpatient care , 2004, The Medical journal of Australia.

[45]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[46]  Á. Avezum,et al.  Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. , 2004, The American journal of medicine.

[47]  Christopher P Cannon,et al.  Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry. , 2002, Critical pathways in cardiology.

[48]  A. Gawlinski,et al.  Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). , 2001, The American journal of cardiology.

[49]  C. Cannon,et al.  Emergency department thrombolysis critical pathway reduces door‐to‐drug times in acute myocardial infarction , 1999, Clinical cardiology.

[50]  S. Solomon,et al.  Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. , 1997, Circulation.

[51]  L E Hinkle,et al.  Clinical Classification of Cardiac Deaths , 1982, Circulation.

[52]  R. Baggott.  DISEASE , 1947, Social Policy & Administration.

[53]  C. Lau,et al.  Incidence and predictors of sudden arrhythmic death or ventricular tachyarrhythmias after acute coronary syndrome: An asian perspective. , 2017, Heart rhythm.

[54]  Baris Gencer,et al.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2011 .

[55]  Min Chul Kim,et al.  Impact of postdischarge statin withdrawal on long-term outcomes in patients with acute myocardial infarction. , 2015, The American journal of cardiology.

[56]  M. Link,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Journal of the American College of Cardiology.

[57]  P. Ostadal.  Statins as first-line therapy for acute coronary syndrome? , 2012, Experimental and clinical cardiology.

[58]  D. Janicke,et al.  Acute coronary syndrome emergency treatment strategies: Improved treatment and reduced mortality in patients with acute coronary syndrome using guideline-based critical care pathways. , 2009, American Heart Journal.

[59]  Shin Aoyama,et al.  The Asian Perspective , 2005 .